Immune Globulin-Ifas (Intravenous Route)
Name: Immune Globulin-Ifas (Intravenous Route)
- Immune Globulin-Ifas Intravenous Route dosage
- Immune Globulin-Ifas Intravenous Route dosage forms
- Immune Globulin-Ifas Intravenous Route injection
Immune globulin-ifas injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral immunodeficiency (PI), including congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and other severe combined immune system problems. It is also used to raise your platelet counts to control or prevent bleeding in adult patients with chronic immune thrombocytopenia (ITP).
This medicine is to be given only by or under the supervision of your doctor.
This product is available in the following dosage forms:
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of immune globulin-ifas injection in children 2 years of age and older. Safety and efficacy have not been established in children with ITP or in children younger than 2 years of age to treat primary humoral immunodeficiency, congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, or Wiskott-Aldrich syndrome.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of immune globulin-ifas injection in the elderly. However, elderly patients are more likely to have age-related blood clotting problems or kidney disease, which may require caution for patients receiving immune globulin-ifas injection.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.